
Elizabeth Bisaccia, PharmD, BCPPS
Advertisement
Articles by Elizabeth Bisaccia, PharmD, BCPPS

Advertisement
Latest Updated Articles
Updates in Clinical Data for FDA-approved Disease-modifying Therapies for Spinal Muscular AtrophyPublished: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
2
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
5



